ORGANIGRAM Corporate Presentation
Liquidity and Capital
.
.
.
Cash and short-term investments of $34.1M as at end of Q1 Fiscal 2020
Generated positive adjusted EBITDA of $4.9M¹ in Q1 Fiscal 2020
$30M in undrawn capacity on total term loan of $115M as of January 14, 2019
A revolver available of up to $25M to be drawn against specified receivables
⚫ Credit facility includes an option to increase to $175M² from $140M
In December 2019, established an at-the-market equity program for further financing flexibility and
has issued ~7.3M common shares for gross proceeds of ~$22.9M as of Jan 12, 2019
⚫ Allows for the issuance of up to C$55M³ of common shares from treasury
• Remaining capacity of $32.1M available as at Jan 12, 2019
• Volume and timing of issuance of common shares at the sole discretion of the Company
1 Adjusted EBITDA is a non-IFRS measure - see Company's Q1 2020 MD&A for definition and a reconciliation to IFRS
18
2
Subject to agreement from lenders and certain legal and business conditions
3
Or US$ equivalent
ORGANIGRAMView entire presentation